Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Instone continues its very solid performance in a still challenging environment; outlook for 2023 confirmed
EQS-News: Instone continues its very solid performance in a still challenging environment; outlook for 2023 confirmed
EQS-News: Instone continues its very solid performance in a still challenging environment; outlook for 2023 confirmed
EQS-News: New Work SE: Recruiting business grows by 7 per cent in first nine months of 2023 amid difficult market environment
EQS-News: New Work SE: Recruiting business grows by 7 per cent in first nine months of 2023 amid difficult market environment
EQS-News: New Work SE: Recruiting business grows by 7 per cent in first nine months of 2023 amid difficult market environment
EQS-News: Continued strong performance in the third quarter of 2023
EQS-News: Continued strong performance in the third quarter of 2023
EQS-News: Continued strong performance in the third quarter of 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-News: SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQS-News: SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQS-News: SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQS-News: TRATON GROUP raises forecast for full-year 2023 following successful business performance in the first nine months
EQS-News: TRATON GROUP raises forecast for full-year 2023 following successful business performance in the first nine months
EQS-News: TRATON GROUP raises forecast for full-year 2023 following successful business performance in the first nine months
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-News: Dermapharm Holding SE publishes  H1 2023 financial report,  confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars
EQS-News: SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars
EQS-News: SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars
EQS-News: Instone continues its very solid performance in a still challenging environment
EQS-News: Instone continues its very solid performance in a still challenging environment
EQS-News: Instone continues its very solid performance in a still challenging environment
EQS-News: SYNLAB AG: Continued strong performance in the second quarter of 2023
EQS-News: SYNLAB AG: Continued strong performance in the second quarter of 2023
EQS-News: SYNLAB AG: Continued strong performance in the second quarter of 2023
EQS-News: TRATON GROUP posts strong increase in unit sales, sales revenue, and operating return on sales in the first half of 2023
EQS-News: TRATON GROUP posts strong increase in unit sales, sales revenue, and operating return on sales in the first half of 2023
EQS-News: TRATON GROUP posts strong increase in unit sales, sales revenue, and operating return on sales in the first half of 2023
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol
EQS-News: SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol
EQS-News: SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Achieves Profitability Already in Q1 2023/2024
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Achieves Profitability Already in Q1 2023/2024
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Achieves Profitability Already in Q1 2023/2024
EQS-News: SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence
EQS-News: SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence
EQS-News: SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence
EQS-News: SYNLAB AG: SYNLAB agrees to sell Swiss business to Sonic Healthcare
EQS-News: SYNLAB AG: SYNLAB agrees to sell Swiss business to Sonic Healthcare
EQS-News: SYNLAB AG: SYNLAB agrees to sell Swiss business to Sonic Healthcare
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Instone Real Estate Group SE: AGM approves dividend distribution of EUR 0.35 per share; Sabine Georgi and Stefan Mohr new members of the Supervisory Board
EQS-News: Instone Real Estate Group SE: AGM approves dividend distribution of EUR 0.35 per share; Sabine Georgi and Stefan Mohr new members of the Supervisory Board
EQS-News: Instone Real Estate Group SE: AGM approves dividend distribution of EUR 0.35 per share; Sabine Georgi and Stefan Mohr new members of the Supervisory Board